Graham Capital Management, L.P. Adaptive Biotechnologies Corp Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,669 shares of ADPT stock, worth $181,814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,669
Previous 40,914
56.81%
Holding current value
$181,814
Previous $245,000
46.53%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$309 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$135 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$115 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$79.6 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.47B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...